Non-Standardized Chemical Allergen [EPC]

Non-Standardized Chemical Allergen [EPC] was reported 77387 times

These side effects are most commonly reported by patients taking drugs of the Non-Standardized Chemical Allergen [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 11925
1 PAIN 4191
2 NAUSEA 3997
3 FATIGUE 3923
4 HEADACHE 3748
5 OFF LABEL USE 3736
6 CONDITION AGGRAVATED 2979
7 DYSPNOEA 2783
8 DIARRHOEA 2723
9 ORAL HERPES 2540
10 PNEUMONIA 2366
11 VOMITING 2307
12 DIZZINESS 2296
13 FALL 2239
14 PYREXIA 2165
15 SINUSITIS 2060
16 PRODUCT DOSE OMISSION ISSUE 2036
17 DEATH 1994
18 MALAISE 1957
19 HYPOTENSION 1930
20 DRUG ADMINISTRATION ERROR 1848
21 RASH 1816
22 ARTHRALGIA 1793
23 ANXIETY 1755
24 URINARY TRACT INFECTION 1737
25 CONSTIPATION 1687
26 ASTHENIA 1682
27 WEIGHT DECREASED 1680
28 BACK PAIN 1660
29 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1641
30 COUGH 1615
31 COVID-19 1524
32 PRURITUS 1511
33 PAIN IN EXTREMITY 1478
34 PRODUCT USE IN UNAPPROVED INDICATION 1472
35 TOXICITY TO VARIOUS AGENTS 1455
36 EYE PAIN 1372
37 ABDOMINAL PAIN 1299
38 EYE IRRITATION 1279
39 NASOPHARYNGITIS 1270
40 RENAL FAILURE 1266
41 ERYTHEMA 1198
42 HYPERTENSION 1192
43 ANAEMIA 1166
44 PRODUCT QUALITY ISSUE 1146
45 VISION BLURRED 1134
46 HYPERSENSITIVITY 1097
47 DECREASED APPETITE 1088
48 INSOMNIA 1060
49 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1040
50 ACUTE KIDNEY INJURY 1027
51 CARDIAC ARREST 1027
52 PRODUCT USE ISSUE 1027
53 SOMNOLENCE 1021
54 DRUG HYPERSENSITIVITY 1018
55 CHEST PAIN 969
56 DEPRESSION 962
57 INFECTION 942
58 BRONCHITIS 934
59 DRUG INTERACTION 919
60 ILLNESS 919
61 BLOOD PRESSURE INCREASED 909
62 MUSCLE SPASMS 905
63 INFUSION RELATED REACTION 893
64 GAIT DISTURBANCE 889
65 FEELING ABNORMAL 883
66 MACULAR DEGENERATION 880
67 CHRONIC KIDNEY DISEASE 878
68 HYPOAESTHESIA 861
69 ANAPHYLACTIC REACTION 855
70 INJECTION SITE PAIN 849
71 CONFUSIONAL STATE 848
72 INCORRECT DRUG ADMINISTRATION DURATION 844
73 SEPSIS 838
74 TREMOR 834
75 WEIGHT INCREASED 830
76 UPPER RESPIRATORY TRACT INFECTION 824
77 CATARACT 814
78 INFLUENZA 810
79 PERIPHERAL SWELLING 810
80 CHILLS 804
81 PARAESTHESIA 797
82 LOSS OF CONSCIOUSNESS 778
83 DEHYDRATION 769
84 URTICARIA 767
85 SEIZURE 762
86 OVERDOSE 754
87 TACHYCARDIA 742
88 HERPES SIMPLEX 738
89 ABDOMINAL PAIN UPPER 733
90 CONTUSION 726
91 MIGRAINE 716
92 LIP SWELLING 700
93 INCORRECT PRODUCT ADMINISTRATION DURATION 696
94 STRESS 684
95 EMOTIONAL DISTRESS 679
96 MYALGIA 674
97 INJURY 665
98 DRY EYE 642
99 VISUAL IMPAIRMENT 639
100 ABDOMINAL DISCOMFORT 637
101 BRADYCARDIA 634
102 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 628
103 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 626
104 OEDEMA PERIPHERAL 617
105 OCULAR HYPERAEMIA 615
106 SWELLING 615
107 MUSCULAR WEAKNESS 612
108 SWELLING FACE 610
109 BALANCE DISORDER 608
110 ALOPECIA 606
111 ATRIAL FIBRILLATION 605
112 OROPHARYNGEAL PAIN 605
113 FEBRILE NEUTROPENIA 599
114 CEREBROVASCULAR ACCIDENT 593
115 UNEVALUABLE EVENT 592
116 ABDOMINAL DISTENSION 589
117 NEUROPATHY PERIPHERAL 588
118 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 586
119 APPLICATION SITE PAIN 580
120 INFUSION SITE PAIN 571
121 DYSPEPSIA 565
122 PRODUCT ADHESION ISSUE 564
123 ASTHMA 558
124 HEART RATE INCREASED 545
125 GASTROOESOPHAGEAL REFLUX DISEASE 544
126 EAR INFECTION 540
127 INCORRECT DOSE ADMINISTERED 530
128 DYSPHAGIA 528
129 RESPIRATORY FAILURE 528
130 HYPERHIDROSIS 525
131 INSURANCE ISSUE 525
132 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 525
133 BURNING SENSATION 523
134 RESPIRATORY TRACT INFECTION 523
135 ANAPHYLACTIC SHOCK 522
136 CHEST DISCOMFORT 519
137 MEMORY IMPAIRMENT 513
138 CELLULITIS 507
139 NECK PAIN 501
140 PALPITATIONS 500
141 SYNCOPE 494
142 INTENTIONAL PRODUCT USE ISSUE 490
143 ARTHRITIS 480
144 HAEMOGLOBIN DECREASED 477
145 GASTROINTESTINAL DISORDER 475
146 HYPOXIA 471
147 DRY MOUTH 463
148 HOSPITALISATION 459
149 BLOOD PRESSURE DECREASED 456
150 OXYGEN SATURATION DECREASED 455
151 PRODUCTIVE COUGH 454
152 JOINT SWELLING 453
153 SEASONAL ALLERGY 447
154 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 443
155 PULMONARY EMBOLISM 443
156 DRUG INTOLERANCE 440
157 RENAL IMPAIRMENT 438
158 RENAL INJURY 437
159 NEUTROPENIA 433
160 MOBILITY DECREASED 431
161 PLEURAL EFFUSION 431
162 INFLUENZA LIKE ILLNESS 430
163 PLATELET COUNT DECREASED 425
164 MUSCULOSKELETAL STIFFNESS 421
165 DEPRESSED LEVEL OF CONSCIOUSNESS 418
166 GENERAL PHYSICAL HEALTH DETERIORATION 418
167 THROMBOSIS 418
168 THROMBOCYTOPENIA 415
169 HERPES ZOSTER 408
170 RHINORRHOEA 408
171 OEDEMA 407
172 ANHEDONIA 405
173 MATERNAL EXPOSURE DURING PREGNANCY 402
174 PRODUCT COMPLAINT 402
175 HAEMORRHAGE 400
176 WHITE BLOOD CELL COUNT DECREASED 398
177 VIRAL INFECTION 397
178 PARAESTHESIA ORAL 394
179 BLOOD GLUCOSE INCREASED 392
180 INFUSION SITE SWELLING 392
181 LACRIMATION INCREASED 391
182 INFUSION SITE ERYTHEMA 390
183 END STAGE RENAL DISEASE 387
184 FLUSHING 386
185 COGNITIVE DISORDER 383
186 FEAR 383
187 BLISTER 380
188 DRY SKIN 380
189 EPISTAXIS 380
190 DISCOMFORT 379
191 PROCEDURAL PAIN 379
192 RHEUMATOID ARTHRITIS 369
193 INTENTIONAL PRODUCT MISUSE 368
194 STOMATITIS 368
195 LETHARGY 363
196 MYOCARDIAL INFARCTION 363
197 NASAL CONGESTION 362
198 DISEASE PROGRESSION 361
199 RECTAL HAEMORRHAGE 359
200 SLEEP DISORDER 359
201 AGITATION 357
202 VENTRICULAR TACHYCARDIA 353
203 NO ADVERSE EVENT 350
204 APPLICATION SITE ERYTHEMA 349
205 STAPHYLOCOCCAL INFECTION 348
206 PHOTOPHOBIA 346
207 HAEMATOCHEZIA 345
208 COLITIS 343
209 DRUG ABUSE 342
210 CYSTITIS 340
211 NEPHROLITHIASIS 340
212 HYPONATRAEMIA 337
213 CARDIAC DISORDER 332
214 THERAPY NON-RESPONDER 329
215 VERTIGO 329
216 WHEEZING 328
217 UNRESPONSIVE TO STIMULI 324
218 ACCIDENTAL EXPOSURE TO PRODUCT 323
219 EYE SWELLING 322
220 EXPOSURE DURING PREGNANCY 320
221 MENTAL STATUS CHANGES 317
222 OSTEOARTHRITIS 316
223 NEURALGIA 315
224 DIABETES MELLITUS 314
225 EXPIRED PRODUCT ADMINISTERED 314
226 MULTIPLE ALLERGIES 312
227 PRODUCT CONTAINER ISSUE 311
228 PULMONARY OEDEMA 311
229 INJECTION SITE ERYTHEMA 310
230 HALLUCINATION 309
231 ADVERSE DRUG REACTION 307
232 CARDIAC FAILURE CONGESTIVE 301
233 CHRONIC SINUSITIS 301
234 DERMATITIS CONTACT 300
235 HYPOKALAEMIA 299
236 DYSPHONIA 298
237 GENERALISED TONIC-CLONIC SEIZURE 298
238 SPEECH DISORDER 296
239 THERAPY INTERRUPTED 293
240 DEEP VEIN THROMBOSIS 292
241 EYE PRURITUS 291
242 TINNITUS 291
243 SUICIDAL IDEATION 288
244 TREATMENT FAILURE 287
245 GASTROINTESTINAL HAEMORRHAGE 285
246 LOWER RESPIRATORY TRACT INFECTION 283
247 DYSARTHRIA 282
248 MALIGNANT NEOPLASM PROGRESSION 282
249 RENAL FAILURE ACUTE 281
250 FOREIGN BODY SENSATION IN EYES 279
251 GASTROENTERITIS VIRAL 279
252 VENTRICULAR FIBRILLATION 279
253 AMNESIA 275
254 CARDIO-RESPIRATORY ARREST 272
255 ORAL CANDIDIASIS 270
256 OSTEOPOROSIS 269
257 FREQUENT BOWEL MOVEMENTS 268
258 DYSGEUSIA 266
259 APPLICATION SITE IRRITATION 264
260 HOT FLUSH 264
261 OCULAR DISCOMFORT 264
262 CARDIAC FAILURE 263
263 BLOOD CREATININE INCREASED 262
264 EYE DISCHARGE 262
265 LOCALISED INFECTION 262
266 MUSCULOSKELETAL PAIN 262
267 SURGERY 262
268 INFUSION SITE PRURITUS 260
269 SKIN DISCOLOURATION 259
270 INFUSION SITE EXTRAVASATION 258
271 SEDATION 258
272 FUNGAL INFECTION 257
273 COMA 256
274 EYE DISORDER 255
275 CROHN^S DISEASE 254
276 ASPARTATE AMINOTRANSFERASE INCREASED 253
277 COLITIS ULCERATIVE 253
278 ALANINE AMINOTRANSFERASE INCREASED 252
279 SKIN EXFOLIATION 252
280 INFUSION SITE HAEMORRHAGE 250
281 MULTI-ORGAN FAILURE 250
282 FLUID RETENTION 248
283 SINUS DISORDER 248
284 METHAEMOGLOBINAEMIA 247
285 BONE PAIN 246
286 CARDIOGENIC SHOCK 245
287 DELIRIUM 245
288 DRUG DOSE OMISSION 245
289 LIMB INJURY 245
290 DYSPNOEA EXERTIONAL 244
291 PANCYTOPENIA 244
292 DIPLOPIA 238
293 KIDNEY INFECTION 238
294 ARTHROPATHY 237
295 BACTERIAL INFECTION 237
296 SCAR 237
297 BLINDNESS 234
298 FEELING HOT 234
299 MEDICATION ERROR 234
300 SEPTIC SHOCK 234
301 BLOOD CHOLESTEROL INCREASED 233
302 MULTIPLE ORGAN DYSFUNCTION SYNDROME 233
303 BLOOD CALCIUM DECREASED 232
304 ELECTROCARDIOGRAM QT PROLONGED 232
305 ORTHOSTATIC HYPOTENSION 232
306 VISUAL ACUITY REDUCED 232
307 FIBROMYALGIA 230
308 PNEUMONIA ASPIRATION 229
309 LUNG DISORDER 227
310 NEPHROGENIC ANAEMIA 227
311 ARRHYTHMIA 226
312 HAEMORRHOIDS 226
313 INFUSION SITE DISCHARGE 226
314 HYPOAESTHESIA ORAL 225
315 LYMPHADENOPATHY 223
316 ROAD TRAFFIC ACCIDENT 223
317 ACCIDENTAL OVERDOSE 222
318 FOETAL EXPOSURE DURING PREGNANCY 222
319 RESPIRATORY DISTRESS 221
320 POOR VENOUS ACCESS 220
321 FLATULENCE 219
322 PSORIASIS 218
323 RASH PRURITIC 218
324 HEART RATE DECREASED 217
325 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 216
326 INJECTION SITE SWELLING 215
327 ANGIOEDEMA 214
328 APPLICATION SITE SWELLING 214
329 INFLAMMATION 214
330 MENTAL DISORDER 214
331 ORAL PAIN 214
332 HEAD INJURY 213
333 ADVERSE EVENT 211
334 INTESTINAL OBSTRUCTION 210
335 SINUS TACHYCARDIA 210
336 DIVERTICULITIS 209
337 THROAT IRRITATION 209
338 POST PROCEDURAL COMPLICATION 208
339 ASCITES 206
340 CONVULSION 205
341 DYSURIA 205
342 PRODUCT USE COMPLAINT 203
343 STATUS EPILEPTICUS 203
344 DISTURBANCE IN ATTENTION 202
345 INJECTION SITE BRUISING 202
346 METABOLIC ACIDOSIS 202
347 NERVOUSNESS 202
348 ORAL DISCOMFORT 202
349 RIB FRACTURE 202
350 WHITE BLOOD CELL COUNT INCREASED 202
351 NEUROTOXICITY 201
352 URINARY RETENTION 199
353 BLOOD POTASSIUM DECREASED 198
354 EYE INFECTION 198
355 IMPAIRED HEALING 198
356 PAIN IN JAW 198
357 DYSKINESIA 197
358 EAR PAIN 197
359 RADICULOPATHY 197
360 HYPERKALAEMIA 195
361 SKIN LACERATION 194
362 ACUTE RESPIRATORY FAILURE 193
363 SKIN ULCER 193
364 DISORIENTATION 191
365 POLLAKIURIA 191
366 CANDIDA INFECTION 190
367 DRUG DEPENDENCE 190
368 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 190
369 DEVICE ISSUE 188
370 INCORRECT DRUG ADMINISTRATION RATE 187
371 RESTLESSNESS 187
372 INJECTION SITE PRURITUS 186
373 SKIN INFECTION 186
374 INFUSION SITE BRUISING 185
375 INTENTIONAL DRUG MISUSE 184
376 SKIN DISORDER 183
377 RENAL DISORDER 182
378 SEDATION COMPLICATION 182
379 NEOPLASM MALIGNANT 181
380 THERAPEUTIC RESPONSE UNEXPECTED 181
381 RESPIRATORY DISORDER 180
382 THERAPEUTIC RESPONSE DECREASED 180
383 HEPATIC ENZYME INCREASED 179
384 TOOTH INFECTION 179
385 CREATININE RENAL CLEARANCE DECREASED 178
386 ENCEPHALOPATHY 178
387 RESPIRATORY ARREST 178
388 CIRCULATORY COLLAPSE 177
389 HYPOTHYROIDISM 177
390 SWOLLEN TONGUE 177
391 TENDERNESS 177
392 RASH ERYTHEMATOUS 176
393 VAGINAL DISCHARGE 175
394 FEMALE GENITAL TRACT FISTULA 174
395 LIMB DISCOMFORT 174
396 WOUND 174
397 PREMATURE BABY 172
398 PRODUCT DISTRIBUTION ISSUE 172
399 URINARY INCONTINENCE 172
400 TOXIC ANTERIOR SEGMENT SYNDROME 170
401 APPLICATION SITE SCAB 169
402 CLOSTRIDIUM DIFFICILE INFECTION 169
403 INTERVERTEBRAL DISC PROTRUSION 169
404 SLEEP APNOEA SYNDROME 169
405 HAEMOPTYSIS 166
406 PROCTITIS 166
407 PRODUCT DOSE OMISSION 166
408 PRODUCT STORAGE ERROR 166
409 RED BLOOD CELL COUNT DECREASED 165
410 BODY TEMPERATURE INCREASED 163
411 FOOT FRACTURE 163
412 IRRITABILITY 162
413 LIP PAIN 162
414 GLAUCOMA 161
415 APHASIA 160
416 PALLOR 160
417 POOR QUALITY SLEEP 160
418 CHEILITIS 159
419 RESPIRATORY DEPRESSION 159
420 HYPERLIPIDAEMIA 158
421 JOINT INJURY 158
422 NEUTROPHIL COUNT DECREASED 158
423 OSTEOMYELITIS 158
424 TRANSIENT ISCHAEMIC ATTACK 158
425 C-REACTIVE PROTEIN INCREASED 157
426 INTENTIONAL OVERDOSE 157
427 MATERNAL EXPOSURE DURING DELIVERY 157
428 CHOLELITHIASIS 156
429 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 156
430 SHOCK 155
431 VAGINAL FLATULENCE 155
432 BRONCHOSPASM 154
433 ECONOMIC PROBLEM 154
434 ECZEMA 154
435 GAIT INABILITY 154
436 ILL-DEFINED DISORDER 154
437 BRAIN OEDEMA 153
438 HAEMATOCRIT DECREASED 153
439 HAEMATURIA 153
440 NERVOUS SYSTEM DISORDER 153
441 NIGHT SWEATS 152
442 PHARYNGITIS STREPTOCOCCAL 152
443 SCIATICA 152
444 HIP FRACTURE 151
445 RESPIRATORY TRACT CONGESTION 151
446 DEPRESSED MOOD 150
447 INJECTION SITE REACTION 149
448 LIP DRY 149
449 ATELECTASIS 148
450 MYDRIASIS 148
451 ANAESTHETIC COMPLICATION 147
452 DYSSTASIA 146
453 HAEMATOMA 146
454 THERAPY PARTIAL RESPONDER 146
455 APPLICATION SITE PRURITUS 145
456 CONJUNCTIVITIS 145
457 HYPOACUSIS 145
458 MUSCLE TWITCHING 145
459 GOUT 144
460 MUCOSAL INFLAMMATION 144
461 PHARYNGITIS 144
462 PRODUCT ADMINISTRATION ERROR 144
463 BLOOD PRESSURE ABNORMAL 143
464 LIVER DISORDER 143
465 THERAPEUTIC PRODUCT EFFECT DECREASED 143
466 DRUG LEVEL INCREASED 142
467 INJECTION SITE HAEMORRHAGE 142
468 IRRITABLE BOWEL SYNDROME 142
469 VENTRICULAR EXTRASYSTOLES 142
470 FEELING COLD 141
471 RASH MACULAR 141
472 TREATMENT NONCOMPLIANCE 141
473 SCAB 140
474 SNEEZING 140
475 MUSCULOSKELETAL CHEST PAIN 139
476 NEEDLE ISSUE 139
477 SKIN IRRITATION 139
478 MYASTHENIA GRAVIS 138
479 VITREOUS FLOATERS 138
480 APPLICATION SITE REACTION 137
481 BLOOD GLUCOSE DECREASED 137
482 BRAIN FOG 137
483 DISABILITY 137
484 PANIC ATTACK 137
485 HYPOGLYCAEMIA 136
486 ACUTE MYOCARDIAL INFARCTION 135
487 COMPLETED SUICIDE 135
488 HYPERSOMNIA 135
489 PULMONARY HYPERTENSION 135
490 SPINAL OSTEOARTHRITIS 135
491 HYPOPHOSPHATAEMIA 134
492 IMPAIRED QUALITY OF LIFE 134
493 PLASMA CELL MYELOMA 134
494 PNEUMOTHORAX 134
495 SEROTONIN SYNDROME 134
496 MUSCULOSKELETAL DISCOMFORT 133
497 SKIN LESION 133
498 TOOTH DISORDER 133
499 HIATUS HERNIA 132
500 MYOCLONUS 132
501 PRODUCT DOSE OMISSION IN ERROR 132
502 GASTRITIS 131
503 APPENDICITIS 130
504 CYTOKINE RELEASE SYNDROME 130
505 DRUG WITHDRAWAL SYNDROME 130
506 SPINAL FRACTURE 130
507 STRESS CARDIOMYOPATHY 130
508 APNOEA 129
509 FACIAL PAIN 129
510 OSTEOPENIA 129
511 IMPAIRED GASTRIC EMPTYING 128
512 LEUKOCYTOSIS 128
513 MULTIPLE SCLEROSIS 128
514 TOOTHACHE 128
515 DRUG EFFECT LESS THAN EXPECTED 127
516 PRODUCT SUBSTITUTION ISSUE 127
517 CEREBRAL HAEMORRHAGE 126
518 LYMPHOCYTE COUNT DECREASED 126
519 PANCREATITIS 126
520 PULSELESS ELECTRICAL ACTIVITY 126
521 THROAT TIGHTNESS 126
522 INTERVERTEBRAL DISC DEGENERATION 125
523 PRESYNCOPE 125
524 PRODUCT ODOUR ABNORMAL 125
525 DRUG EFFECT DECREASED 124
526 HAEMODYNAMIC INSTABILITY 124
527 LEUKOPENIA 124
528 AGGRESSION 123
529 CARPAL TUNNEL SYNDROME 123
530 CORONARY ARTERY DISEASE 123
531 HYPOPHAGIA 123
532 THERAPY CESSATION 123
533 CYANOSIS 122
534 ULCER 122
535 MULTIPLE SCLEROSIS RELAPSE 121
536 TACHYPNOEA 121
537 BLOOD ALKALINE PHOSPHATASE INCREASED 120
538 BLOOD PRESSURE FLUCTUATION 120
539 CHAPPED LIPS 120
540 INTERSTITIAL LUNG DISEASE 120
541 MOVEMENT DISORDER 120
542 SINUS CONGESTION 120
543 ROTATOR CUFF SYNDROME 119
544 SINUS BRADYCARDIA 119
545 WITHDRAWAL SYNDROME 119
546 BLOOD UREA INCREASED 118
547 GASTROINTESTINAL INFECTION 118
548 HYPERGLYCAEMIA 118
549 HYPERPARATHYROIDISM SECONDARY 118
550 BONE DENSITY DECREASED 117
551 CHROMATURIA 117
552 INTENTIONAL DOSE OMISSION 117
553 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 116
554 WEIGHT FLUCTUATION 116
555 ACNE 115
556 DEMENTIA 115
557 INJECTION SITE MASS 115
558 BONE DISORDER 114
559 DEVICE INFUSION ISSUE 114
560 INCORRECT ROUTE OF DRUG ADMINISTRATION 114
561 PREMATURE DELIVERY 114
562 SKIN BURNING SENSATION 114
563 TOOTH ABSCESS 114
564 UPPER LIMB FRACTURE 114
565 ABNORMAL SENSATION IN EYE 113
566 CRYING 113
567 HALLUCINATION, VISUAL 113
568 PULMONARY MASS 113
569 EATING DISORDER 112
570 JOINT STIFFNESS 112
571 TUBULOINTERSTITIAL NEPHRITIS 112
572 APPLICATION SITE VESICLES 111
573 COVID-19 PNEUMONIA 111
574 PSORIATIC ARTHROPATHY 111
575 BLOOD BILIRUBIN INCREASED 110
576 DEVICE DISLOCATION 110
577 DEVICE MALFUNCTION 110
578 EYE INFLAMMATION 110
579 HEART RATE IRREGULAR 110
580 KOUNIS SYNDROME 110
581 LIVER FUNCTION TEST INCREASED 110
582 PROCTALGIA 110
583 PSEUDOMONAS INFECTION 110
584 SYSTEMIC LUPUS ERYTHEMATOSUS 110
585 APPLICATION SITE SCAR 109
586 BLOOD SODIUM DECREASED 109
587 EYELID PTOSIS 109
588 HERNIA 109
589 MASS 109
590 RESPIRATORY SYNCYTIAL VIRUS INFECTION 108
591 TASTE DISORDER 108
592 UNDERDOSE 108
593 EYELID PAIN 107
594 MENTAL IMPAIRMENT 107
595 RESTLESS LEGS SYNDROME 107
596 DRUG EFFECT INCOMPLETE 106
597 NERVE INJURY 106
598 PERICARDIAL EFFUSION 106
599 PNEUMONITIS 106
600 ANKLE FRACTURE 105
601 BACK DISORDER 105
602 BLOOD URINE PRESENT 105
603 MOUTH ULCERATION 105
604 OSTEONECROSIS 105
605 PRODUCT ADMINISTRATION INTERRUPTED 105
606 SMALL INTESTINAL OBSTRUCTION 105
607 APHONIA 104
608 BREAST CANCER 104
609 GASTRIC DISORDER 104
610 IRON DEFICIENCY 104
611 LIP BLISTER 104
612 RETCHING 104
613 ANGINA PECTORIS 103
614 DEAFNESS 103
615 DECUBITUS ULCER 103
616 LIVE BIRTH 103
617 MUSCLE TIGHTNESS 103
618 SUICIDE ATTEMPT 103
619 BLOOD PRESSURE SYSTOLIC INCREASED 102
620 LOWER LIMB FRACTURE 102
621 PARALYSIS 102
622 SPINAL PAIN 102
623 EJECTION FRACTION DECREASED 101
624 HYPERPHOSPHATAEMIA 101
625 PRODUCT AVAILABILITY ISSUE 101
626 RHABDOMYOLYSIS 101
627 CARDIOMEGALY 100
628 CLOSTRIDIUM DIFFICILE COLITIS 100
629 DEVICE RELATED INFECTION 100
630 INFUSION SITE MASS 100
631 LIP HAEMORRHAGE 100
632 OBSTRUCTION 100
633 ALTERED STATE OF CONSCIOUSNESS 99
634 DERMATITIS 99
635 HORNER^S SYNDROME 99
636 NIGHTMARE 99
637 APPLICATION SITE HAEMORRHAGE 98
638 DEVICE DIFFICULT TO USE 98
639 DRUG TOXICITY 98
640 EYELID OEDEMA 98
641 INFUSION SITE REACTION 98
642 INTRAOCULAR PRESSURE INCREASED 98
643 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 98
644 NEOPLASM PROGRESSION 98
645 WRONG TECHNIQUE IN DRUG USAGE PROCESS 98
646 BLOOD PHOSPHORUS INCREASED 97
647 BLOOD URIC ACID INCREASED 97
648 HEPATIC FUNCTION ABNORMAL 97
649 PULSE ABSENT 97
650 RENAL TUBULAR NECROSIS 97
651 SKIN CANCER 97
652 TYPE 2 DIABETES MELLITUS 97
653 ERYTHEMA OF EYELID 96
654 FULL BLOOD COUNT DECREASED 96
655 HEMIPARESIS 95
656 POST PROCEDURAL INFECTION 95
657 ABSCESS 94
658 BRONCHIECTASIS 94
659 COAGULOPATHY 94
660 COLD SWEAT 94
661 FEEDING DISORDER 94
662 MALNUTRITION 94
663 HEAD DISCOMFORT 93
664 HEPATIC FAILURE 93
665 PULMONARY CONGESTION 93
666 AGEUSIA 92
667 EMOTIONAL DISORDER 92
668 RASH MACULO-PAPULAR 92
669 BURSITIS 91
670 EYE OPERATION 91
671 HAEMATEMESIS 91
672 HYPERAESTHESIA 91
673 INTERNATIONAL NORMALISED RATIO INCREASED 91
674 LIGAMENT SPRAIN 91
675 RASH PAPULAR 91
676 SENSORY LOSS 91
677 SUPRAVENTRICULAR TACHYCARDIA 91
678 TROPONIN INCREASED 91
679 APPLICATION SITE PARAESTHESIA 90
680 BACTERAEMIA 90
681 NERVE COMPRESSION 90
682 APPENDICOLITH 89
683 ASTHENOPIA 89
684 EPILEPSY 89
685 ILEUS 89
686 INFUSION SITE RASH 89
687 LACTIC ACIDOSIS 89
688 OBSTRUCTIVE AIRWAYS DISORDER 89
689 STREPTOCOCCAL INFECTION 89
690 VITAMIN D DEFICIENCY 89
691 APPLICATION SITE DISCOLOURATION 88
692 HEPATIC STEATOSIS 88
693 INSPIRATORY CAPACITY DECREASED 88
694 LARYNGITIS 88
695 POOR QUALITY PRODUCT ADMINISTERED 88
696 PRODUCT PRESCRIBING ISSUE 88
697 QUALITY OF LIFE DECREASED 88
698 BODY HEIGHT DECREASED 87
699 FAECES DISCOLOURED 87
700 IMPAIRED WORK ABILITY 87
701 JOINT RANGE OF MOTION DECREASED 87
702 APPLICATION SITE RASH 86
703 BLADDER DISORDER 86
704 DEAFNESS NEUROSENSORY 86
705 DYSTONIA 86
706 IRON DEFICIENCY ANAEMIA 86
707 NODULE 86
708 STEVENS-JOHNSON SYNDROME 86
709 TORSADE DE POINTES 86
710 ACCIDENT 85
711 ACUTE RESPIRATORY DISTRESS SYNDROME 85
712 DISSEMINATED INTRAVASCULAR COAGULATION 85
713 OSTEONECROSIS OF JAW 85
714 RENAL CYST 85
715 TENDONITIS 85
716 ABDOMINAL PAIN LOWER 84
717 ABNORMAL BEHAVIOUR 84
718 BASAL CELL CARCINOMA 84
719 CARDIOTOXICITY 84
720 PHOTOSENSITIVITY REACTION 84
721 WOUND INFECTION 84
722 ACTIVITIES OF DAILY LIVING IMPAIRED 83
723 ASPIRATION 83
724 BLOOD POTASSIUM INCREASED 83
725 EXOSTOSIS 83
726 PULMONARY FIBROSIS 83
727 SWELLING OF EYELID 83
728 CONCUSSION 82
729 FOOD ALLERGY 82
730 GASTRIC ULCER 82
731 HEREDITARY ANGIOEDEMA 82
732 MICTURITION URGENCY 82
733 RENAL FUNCTION TEST ABNORMAL 82
734 VAGINAL HAEMORRHAGE 82
735 ANAL INCONTINENCE 81
736 DISEASE RECURRENCE 81
737 ENDOPHTHALMITIS 81
738 GALLBLADDER DISORDER 81
739 HYPOMAGNESAEMIA 81
740 INCONTINENCE 81
741 MITRAL VALVE INCOMPETENCE 81
742 NEUTROPHIL COUNT INCREASED 81
743 SKIN ABRASION 81
744 SPINAL OPERATION 81
745 UPPER-AIRWAY COUGH SYNDROME 81
746 BLOOD CALCIUM INCREASED 80
747 BLOOD IRON DECREASED 80
748 CYST 80
749 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 80
750 ESCHERICHIA INFECTION 80
751 GLOSSODYNIA 80
752 HORDEOLUM 80
753 PROCEDURAL COMPLICATION 80
754 AUTOIMMUNE DISORDER 79
755 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 79
756 FACE OEDEMA 79
757 FLANK PAIN 79
758 THERAPEUTIC RESPONSE SHORTENED 79
759 BLOOD TRIGLYCERIDES INCREASED 78
760 CARDIOMYOPATHY 78
761 DEVICE LEAKAGE 78
762 LABORATORY TEST ABNORMAL 78
763 MUSCLE STRAIN 78
764 THINKING ABNORMAL 78
765 TOXIC EPIDERMAL NECROLYSIS 78
766 CORNEAL OEDEMA 77
767 ELECTROLYTE IMBALANCE 77
768 GRAND MAL CONVULSION 77
769 REBOUND ACID HYPERSECRETION 77
770 SKIN REACTION 77
771 SPUTUM DISCOLOURED 77
772 ARTHRITIS INFECTIVE 76
773 ATAXIA 76
774 BLOOD CREATINE PHOSPHOKINASE INCREASED 76
775 HYPERCHOLESTEROLAEMIA 76
776 PREGNANCY 76
777 TOOTH LOSS 76
778 VASCULAR DEVICE INFECTION 76
779 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 75
780 ARTHROPOD BITE 75
781 DENTAL CARIES 75
782 FACIAL PARALYSIS 75
783 GENERALISED OEDEMA 75
784 HYPOCALCAEMIA 75
785 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 75
786 PNEUMONIA BACTERIAL 75
787 SKIN WARM 75
788 UROSEPSIS 75
789 ANGER 74
790 GLUCOSE TOLERANCE IMPAIRED 74
791 HOSPICE CARE 74
792 MOTOR DYSFUNCTION 74
793 PARKINSON^S DISEASE 74
794 PRODUCT PREPARATION ERROR 74
795 PSYCHOTIC DISORDER 74
796 RHINOVIRUS INFECTION 74
797 SPINAL DISORDER 74
798 BLOOD TEST ABNORMAL 73
799 EMPHYSEMA 73
800 JOINT DISLOCATION 73
801 PRE-EXISTING CONDITION IMPROVED 73
802 RENAL FAILURE CHRONIC 73
803 THYROID DISORDER 73
804 UPPER GASTROINTESTINAL HAEMORRHAGE 73
805 BLINDNESS UNILATERAL 72
806 BUNDLE BRANCH BLOCK LEFT 72
807 LOCAL SWELLING 72
808 RETINAL DETACHMENT 72
809 SJOGREN^S SYNDROME 72
810 WRIST FRACTURE 72
811 APPLICATION SITE BURN 71
812 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 71
813 LIQUID PRODUCT PHYSICAL ISSUE 71
814 MADAROSIS 71
815 MIOSIS 71
816 PARANOIA 71
817 CEREBRAL INFARCTION 70
818 COMPLICATION ASSOCIATED WITH DEVICE 70
819 CONTRAINDICATED PRODUCT ADMINISTERED 70
820 MUSCLE RIGIDITY 70
821 PHARYNGEAL SWELLING 70
822 RASH GENERALISED 70
823 APPLICATION SITE DRYNESS 69
824 HEPATIC CIRRHOSIS 69
825 LEFT VENTRICULAR DYSFUNCTION 69
826 LIP DISORDER 69
827 MOUTH SWELLING 69
828 NEPHROPATHY 69
829 NYSTAGMUS 69
830 THIRST 69
831 BLOOD MAGNESIUM DECREASED 68
832 DIZZINESS POSTURAL 68
833 DRUG-INDUCED LIVER INJURY 68
834 EYE HAEMORRHAGE 68
835 FEMUR FRACTURE 68
836 OBESITY 68
837 OESOPHAGITIS 68
838 PELVIC PAIN 68
839 SENSORY DISTURBANCE 68
840 THERAPEUTIC PRODUCT EFFECT DELAYED 68
841 BACK INJURY 67
842 BLOOD ALBUMIN DECREASED 67
843 DEVICE OCCLUSION 67
844 EAR DISCOMFORT 67
845 LUNG INFECTION 67
846 MENINGITIS 67
847 POST PROCEDURAL HAEMORRHAGE 67
848 BRAIN INJURY 66
849 DERMATITIS ATOPIC 66
850 PERICARDITIS 66
851 PERIPHERAL COLDNESS 66
852 SPINAL COMPRESSION FRACTURE 66
853 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 65
854 DRUG ADMINISTERED AT INAPPROPRIATE SITE 65
855 ENDOCRINE OPHTHALMOPATHY 65
856 HAIR COLOUR CHANGES 65
857 HYPOKINESIA 65
858 INABILITY TO AFFORD MEDICATION 65
859 MOOD ALTERED 65
860 ORAL DISORDER 65
861 EXTRA DOSE ADMINISTERED 64
862 KNEE ARTHROPLASTY 64
863 METASTASES TO BONE 64
864 PRURITUS GENERALISED 64
865 RALES 64
866 SECRETION DISCHARGE 64
867 TRANSAMINASES INCREASED 64
868 APHTHOUS ULCER 63
869 BLINDNESS TRANSIENT 63
870 BREATH SOUNDS ABNORMAL 63
871 ECCHYMOSIS 63
872 FOOD POISONING 63
873 FOOT DEFORMITY 63
874 INFUSION SITE WARMTH 63
875 INSTILLATION SITE PAIN 63
876 LUNG INFILTRATION 63
877 LYMPHOEDEMA 63
878 POSTOPERATIVE WOUND INFECTION 63
879 SARS-COV-2 TEST POSITIVE 63
880 SKIN FISSURES 63
881 TOOTH EXTRACTION 63
882 TYPE I HYPERSENSITIVITY 63
883 AORTIC STENOSIS 62
884 ATRIOVENTRICULAR BLOCK COMPLETE 62
885 IMMUNE SYSTEM DISORDER 62
886 INADEQUATE ANALGESIA 62
887 INFUSION SITE DISCOMFORT 62
888 MELAENA 62
889 MYOCARDIAL ISCHAEMIA 62
890 OTITIS MEDIA 62
891 PERIORBITAL PAIN 62
892 PERIPHERAL VASCULAR DISORDER 62
893 PULMONARY THROMBOSIS 62
894 RHINITIS 62
895 SCRATCH 62
896 TRICUSPID VALVE INCOMPETENCE 62
897 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 62
898 ANALGESIC THERAPY 61
899 ARTHRITIS BACTERIAL 61
900 DRUG THERAPY 61
901 EYELID MARGIN CRUSTING 61
902 MENINGITIS ASEPTIC 61
903 PARAPLEGIA 61
904 PRODUCT PHYSICAL ISSUE 61
905 PROTEINURIA 61
906 RENAL PAIN 61
907 SCLERAL HYPERAEMIA 61
908 SLEEP DISORDER THERAPY 61
909 THERMAL BURN 61
910 VASOPLEGIA SYNDROME 61
911 JAUNDICE 60
912 JOINT EFFUSION 60
913 MIDDLE INSOMNIA 60
914 RESPIRATORY ACIDOSIS 60
915 BEDRIDDEN 59
916 DERMATITIS ALLERGIC 59
917 GROIN PAIN 59
918 HAND FRACTURE 59
919 HEPATITIS 59
920 HYPOALBUMINAEMIA 59
921 INFUSION SITE IRRITATION 59
922 INFUSION SITE URTICARIA 59
923 LIVER FUNCTION TEST ABNORMAL 59
924 METASTASES TO CENTRAL NERVOUS SYSTEM 59
925 MULTIPLE DRUG THERAPY 59
926 MUSCLE ATROPHY 59
927 MUSCULOSKELETAL DISORDER 59
928 PAIN OF SKIN 59
929 RHINITIS ALLERGIC 59
930 TOOTH FRACTURE 59
931 VARICOSE VEIN 59
932 WALKING AID USER 59
933 ARTERIOSCLEROSIS 58
934 CHOKING 58
935 DEVICE BREAKAGE 58
936 DIVERTICULUM 58
937 DRUG EXPOSURE DURING PREGNANCY 58
938 EYE MOVEMENT DISORDER 58
939 GASTROINTESTINAL PAIN 58
940 GINGIVAL BLEEDING 58
941 GLYCOSYLATED HAEMOGLOBIN INCREASED 58
942 HAIR TEXTURE ABNORMAL 58
943 HEPATOMEGALY 58
944 HYPERTENSIVE CRISIS 58
945 ORAL MUCOSAL BLISTERING 58
946 OROPHARYNGEAL DISCOMFORT 58
947 PSYCHOMOTOR HYPERACTIVITY 58
948 PULMONARY ARTERIAL HYPERTENSION 58
949 PYELONEPHRITIS 58
950 TENDON RUPTURE 58
951 CHOLECYSTITIS 57
952 EXTRAPYRAMIDAL DISORDER 57
953 FEELING JITTERY 57
954 HYPERTHERMIA MALIGNANT 57
955 LUNG OPACITY 57
956 NOCTURIA 57
957 NORMAL NEWBORN 57
958 PELVIC FRACTURE 57
959 POST-TRAUMATIC STRESS DISORDER 57
960 RETINAL HAEMORRHAGE 57
961 WRONG PRODUCT ADMINISTERED 57
962 EXPOSURE VIA SKIN CONTACT 56
963 HYPERTHYROIDISM 56
964 HYPERVOLAEMIA 56
965 MOOD SWINGS 56
966 NEOPLASM 56
967 SENSITIVE SKIN 56
968 VENTRICULAR HYPOKINESIA 56
969 ARTERIOSCLEROSIS CORONARY ARTERY 55
970 EYELID IRRITATION 55
971 FLUID OVERLOAD 55
972 IMMUNODEFICIENCY 55
973 INJECTION SITE RASH 55
974 PARANASAL SINUS DISCOMFORT 55
975 RESPIRATORY TRACT INFECTION VIRAL 55
976 SPINAL CORD COMPRESSION 55
977 VENTRICULAR ARRHYTHMIA 55
978 ABNORMAL DREAMS 54
979 APPETITE DISORDER 54
980 BENIGN PROSTATIC HYPERPLASIA 54
981 CARDIOVASCULAR DISORDER 54
982 COORDINATION ABNORMAL 54
983 DELUSION 54
984 EOSINOPHILIA 54
985 GRAVES^ DISEASE 54
986 HYDRONEPHROSIS 54
987 HYPERKERATOSIS 54
988 LACERATION 54
989 LUNG NEOPLASM MALIGNANT 54
990 RESPIRATORY RATE INCREASED 54
991 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 54
992 GINGIVITIS 53
993 HIP ARTHROPLASTY 53
994 HYPOTONIA 53
995 IMPAIRED DRIVING ABILITY 53
996 LIP EXFOLIATION 53
997 LIVER INJURY 53
998 POISONING 53
999 PRESCRIBED OVERDOSE 53